Capsaicin and sorafenib combination treatment exerts synergistic anti‑hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling
Authors:
Open Access
- 1 October 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 40 (6) , 3235-3248
Abstract
Capsaicin (8‑methyl N‑vanillyl‑6 nonenamide) is a natural plant extract that has antitumor properties and induces apoptosis and autophagy in various types of malignancies, including hepatocellular carcinoma (HCC). Sorafenib is a multi‑kinase inhibitor that improves the survival of patients with advanced HCC. In the present study, capsaicin and sorafenib were found to inhibit the growth of LM3, Hep3B and HuH7 cells. In addition, the combination of capsaicin and sorafenib exerted a synergistic inhibitory effect on HCC cell growth. In LM3 cells, capsaicin and sorafenib combination treatment achieved a markedly stronger induction of apoptosis by increasing caspase‑3, Bax and poly(ADP‑ribose) polymerase activity and inhibiting Bcl‑2, and induction of autophagy by upregulating the levels of beclin‑1 and LC3A/B II, enhancing P62 degradation. The combination of capsaicin and sorafenib also inhibited cell invasion and metastasis via upregulation of E‑cadherin and downregulation of N‑cadherin, vimentin, matrix metalloproteinase (MMP)2 and MMP9. Additional studies suggested an association between the abovementioned anticancer activities and inhibition of the epidermal growth factor receptor/phosphoinositide 3 kinase/Akt/mammalian target of rapamycin pathway. Taken together, these data confirm that capsaicin and sorafenib combination treatment inhibits the growth, invasion and metastasis of HCC cells and induces autophagy in a synergistic manner, supporting its potential as a therapeutic option for HCC.Keywords
This publication has 39 references indexed in Scilit:
- IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathwayMolecular Immunology, 2017
- Capsaicin Induces Autophagy and Apoptosis in Human Nasopharyngeal Carcinoma Cells by Downregulating the PI3K/AKT/mTOR PathwayInternational Journal of Molecular Sciences, 2017
- Targeting breast cancer cells by MRS1477, a positive allosteric modulator of TRPV1 channelsPLOS ONE, 2017
- C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cellsApplied Microbiology and Biotechnology, 2016
- Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinomaWorld Journal of Gastroenterology, 2015
- Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic ReviewDigestive Diseases and Sciences, 2012
- Regulation Mechanisms and Signaling Pathways of AutophagyAnnual Review of Genetics, 2009
- Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesisWorld Journal of Gastroenterology, 2008
- Involvement of AMPK Signaling Cascade in Capsaicin‐Induced Apoptosis of HT‐29 Colon Cancer CellsAnnals of the New York Academy of Sciences, 2007
- PI3K induced actin filament remodeling through Akt and p70S6K1: implication of essential role in cell migrationAmerican Journal of Physiology-Cell Physiology, 2004